|
Camazepam
|
|
| Systematic (IUPAC) name | |
| (9-chloro- 2-methyl- 3-oxo- 6-phenyl- 2,5-diazabicyclo [5.4.0]undeca- 5,8,10,12-tetraen- 4-yl) N,N-dimethylcarbamate | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H18ClN3O3 |
| Mol. mass | 371.8 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Camazepam (marketed under the brand names Albego, Limpidon, and Paxor) is the dimethyl carbamate ester of temazepam, a metabolite of diazepam. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Compared to temazepam, camazepam has shown roughly equal anxiolytic properties, and less anticonvulsant, sedative and motor-impairing properties.
See also
External links
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)



